Schedule 13D ownership disclosure

Sarepta Therapeutics Inc

Security class unavailable · CUSIP: 803607100

Event date: 2015-04-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,165,014
Percent of class
7.6600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001562371-15-000003
Form type
SC 13D
Filer
Barry Richard
CIK
CIK 1562371
Filed
May 05, 2015
Reporting period
Apr 20, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub